Page last updated: 2024-09-05

3-o-methyl-6-fluoro-dopa and Thyroid Neoplasms

3-o-methyl-6-fluoro-dopa has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J	1

Other Studies

1 other study(ies) available for 3-o-methyl-6-fluoro-dopa and Thyroid Neoplasms

Article	Year
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:10 Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms	2007

Article

Year

Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.

European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:10

Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms

2007